Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FYP51
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,245
Award facts
- Contract value 100% obligated
- $17,245.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of XTANDI 40 mg capsules (120 count). This $17,245.40 firm fixed-price delivery order, awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a critical pharmaceutical supply for oncology support within the Department of Defense healthcare system. The contract carries no set-aside designation, and DMS Pharmaceutical Group competed for this award leveraging its established vendor status and extensive pharmaceutical distribution capabilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. The parent IDC enables the agency to procure a comprehensive range of pharmaceutical products—including branded and generic prescription drugs, biologics, and medical consumables—to support military health facilities worldwide. DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, consistently securing contracts with DLA for diverse pharmaceutical products spanning oncology treatments, vaccines, and specialty medications that serve critical medical needs across Department of Defense healthcare networks.
Quick answers
Who was awarded contract SPE2DB25FYP51?
SPE2DB25FYP51 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FYP51 worth?
The government has obligated $17,245 on SPE2DB25FYP51.
Is contract SPE2DB25FYP51 an order under another contract?
Yes. SPE2DB25FYP51 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP51 competed?
The extent of competition for SPE2DB25FYP51 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award